Back to top
more

Franklin Strategic Biotechnology Discovery Fund Class A: (MF: FBDIX)

(NASDAQ Mutual Funds) As of Jun 17, 2021 08:00 PM ET

 Add to portfolio

$163.54 USD

+0.41 (0.25%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

4-Sell of 5       4  

View All Zacks Mutual Fund Rank #1's

Latest Performance as of May 31, 2021

Total Return %* Percentile Rank Objective
YTD -10.01 94
3 months -11.18 94
6 months -6.80 94
1 Year 6.70 98
3 Year 9.16 95
5 Year 9.50 88
10 Year 14.22 50

* Annual for three years and beyond.

Zacks Premium Research for FBDIX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Sell 4
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 42.67
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 5/31/2021 1,088.19
%Turnover 5/31/2021 32.92

Risk

3 Year 5 Year 10 Year
Beta 0.91 0.96 1.04
Alpha -5.06 -4.68 1.13
R Squared 0.48 0.40 0.37
Std. Dev. 24.57 22.82 23.37
Sharpe 0.45 0.49 3.00

Sector / Country Weightings

As of 5/31/2021 % of Portfolio
Health 74.02
Other 13.75
Services 6.42
Technology 4.55
Finance 1.26

Portfolio Holdings

Top Equity Holdings
(As of 1/31/2021)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 6.42 99.18
VERTEX PHARMACEUTICALS IN 5.45 84.21
REGENERON PHARMACEUTICALS 5.05 78.05
AMGEN INC 4.98 76.94
ILLUMINA INC 4.55 70.36
GW PHARMACEUTICALS PLC 4.54 70.18
IOVANCE BIOTHERAPEUTICS I 3.96 61.20
NOVAVAX INC 3.45 53.38
PTC THERAPEUTICS INC 2.87 44.28

Stock Holding % of Net Assets

As Of 1/31/2021
Total Issues 101
Avg. P/E 36.64
Avg. P/Book 5.68
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 31,681

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 34.15
Small Value 0.00
Foreign Stock 0.00
Emerging Market 2.88
Precious Metal 0.06
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 28.65